| 000 | 01062 a2200289 4500 | ||
|---|---|---|---|
| 005 | 20250517041303.0 | ||
| 264 | 0 | _c20160615 | |
| 008 | 201606s 0 0 eng d | ||
| 022 | _a1179-1934 | ||
| 024 | 7 |
_a10.1007/s40263-015-0253-z _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aWrobel Goldberg, Stephanie | |
| 245 | 0 | 0 |
_aTargeting CGRP: A New Era for Migraine Treatment. _h[electronic resource] |
| 260 |
_bCNS drugs _cJun 2015 |
||
| 300 |
_a443-52 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 |
_aAnalgesics _xtherapeutic use |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aCalcitonin Gene-Related Peptide _xmetabolism |
| 650 | 0 | 4 | _aCalcitonin Gene-Related Peptide Receptor Antagonists |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aMigraine Disorders _xdrug therapy |
| 650 | 0 | 4 |
_aReceptors, Calcitonin Gene-Related Peptide _xmetabolism |
| 700 | 1 | _aSilberstein, Stephen David | |
| 773 | 0 |
_tCNS drugs _gvol. 29 _gno. 6 _gp. 443-52 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/s40263-015-0253-z _zAvailable from publisher's website |
| 999 |
_c25040641 _d25040641 |
||